| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Type 2 diabetes is a chronic condition where the body either doesn’t produce enough insulin or doesn’t use it effectively, causing high blood sugar levels. Insulin is crucial for helping the body convert glucose into energy. When insulin doesn’t work properly, glucose accumulates in the bloodstream, leading to increased blood sugar. Over time, this can result in serious complications such as organ damage and a higher risk of heart attack or stroke. “Diabetes can affect every organ system,” says Sanjay Dixit, MD, medical director of cardiometabolic endocrine and wellness clinical solutions at Quest Diagnostics. “Early detection and management of type 2 diabetes is crucial.”
Quest Diagnostics on Monday completed its acquisition of select lab assets of Allina Health in a deal that builds on the industry trend of independent companies taking over the outpatient lab operations of health systems.
Quest Diagnostics and Sentara Health Plans said Wednesday that they have entered into a multi-year strategic collaboration. Under the agreement, Quest will, at the beginning of 2025, become the exclusive independent national laboratory provider of clinical laboratory and anatomic pathology services for Sentara members in Florida and Virginia.
Adherence to guideline-based laboratory testing and treatment of chlamydia and gonorrhea in pregnant women has been found to be suboptimal in the United States, indicating the potential for negative effects on newborn and maternal health, according to a recently published study in the Journal of Lower Genital Tract Disease. Researchers from Quest Diagnostics and the University of Alabama sought to evaluate adherence to national recommendations for chlamydia and gonorrhea testing during pregnancy. This evaluation also included tests for persistence/potential reinfection at time of delivery and cure/clearance.
A critical technique in clinical laboratory testing, mass spectrometry (MS) involves, at its core, examining a mass of molecules. Darren Weber, Associate Scientific Director in the R&D Mass Spectrometry department at Quest Diagnostics-Nichols Institute in San Juan Capistrano, explains mass spectrometry’s place in the clinical lab.